Mylan, Pfizer Headed to Trial Over Norvasc Patent

Drug Industry Daily
KEYWORDS courts / Patents
A A

A federal judge has rejected Pfizer's request to throw out Mylan Laboratories' lawsuit challenging the patents on blockbuster blood pressure treatment Norvasc.

To View This Article:

Login

Subscribe To Drug Industry Daily